Zeng Li-Qin, Peng Zhi-Lan
Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Chengdu 610041, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Jan;27(1):84-7, 91.
To construct THY1 eukaryotic expression plasmid and study its effects on the growth of epithelial ovarian cancer cell line SKOV3.
THY1 gene fragment was obtained from normal human ovarian tissue using RT-PCR, and inserted into the eukaryotic expression plasmid pcDNA3.1(+) to construct the recombinant plasmid pcDNA3.1(+)-THY1, which was transformed into E. coli JM109 followed by selection of the positive clones containing the target inserts. The eukaryotic expression plasmid was analyzed by PCR, restriction endonucleases digestion and DNA sequencing. SKOV3 cells divided into SKOV3-THY1, SKOV-3-Null and SKOV3 groups were transfected via liposome with the recombinant plasmid pcDNA3.1(+)-THY1, empty plasmid, or not transfected, respectively. The expression of THY1 mRNA and its protein were examined by RT-PCR and Western blot methods. The cell growth and apoptosis were evaluated by MTT assay and flow cytometry.
The gene fragment of exogenous THY1 was correctly inserted into the eukaryotic expression plasmid pcDNA3.1(+) as verified by PCR, restriction endonucleases digestion and DNA sequencing, and recombinant expression plasmid pcDNA3.1(+)-THY1 transfection resulted in stable expression in SKOV3 cells as shown by RT-PCR and Western blotting. The cell growth inhibition rate of SKOV3-THY1 group (56.6% at the fifth day) was significantly higher than that of the SKOV3-Null group (12.5%, P<0.05), and the cell apoptosis rate in SKOV3-THY1 group (31.8%) was significantly higher than those in SKOV3-Null group (10.5%) and SKOV3 group (9.8%, P<0.05), but the apoptosis rate between the latter two groups was similar (P>0.05).
The recombinant plasmid pcDNA3.1(+)-THY1 can be expressed stably in human ovarian cancer cell line SKOV3. THY1 transfection can inhibit the growth of SKOV3 cells in vitro, suggesting the important role of THY1 gene in pathogenesis and development of ovarian cancer.
构建THY1真核表达质粒并研究其对上皮性卵巢癌细胞系SKOV3生长的影响。
采用逆转录聚合酶链反应(RT-PCR)从正常人卵巢组织中获取THY1基因片段,将其插入真核表达质粒pcDNA3.1(+)中构建重组质粒pcDNA3.1(+)-THY1,转化至大肠杆菌JM109中,筛选出含目的插入片段的阳性克隆。通过聚合酶链反应(PCR)、限制性内切酶消化及DNA测序对真核表达质粒进行分析。将SKOV3细胞分为SKOV3-THY1组、SKOV-3-Null组和SKOV3组,分别用重组质粒pcDNA3.1(+)-THY1、空质粒或不转染,通过脂质体转染。采用RT-PCR和蛋白质免疫印迹法检测THY1 mRNA及其蛋白的表达。通过MTT法和流式细胞术评估细胞生长和凋亡情况。
经PCR、限制性内切酶消化及DNA测序验证,外源性THY1基因片段正确插入真核表达质粒pcDNA3.1(+)中,RT-PCR和蛋白质免疫印迹法显示重组表达质粒pcDNA3.1(+)-THY1转染后在SKOV-3细胞中稳定表达。SKOV3-THY1组细胞生长抑制率(第5天为56.6%)显著高于SKOV3-Null组(12.5%,P<0.05),SKOV3-THY1组细胞凋亡率(31.8%)显著高于SKOV3-Null组(10.5%)和SKOV3组(9.8%,P<0.05),但后两组凋亡率相似(P>0.05)。
重组质粒pcDNA3.1(+)-THY1可在人卵巢癌细胞系SKOV3中稳定表达。THY1转染可在体外抑制SKOV3细胞生长,提示THY1基因在卵巢癌发病机制及发展中起重要作用。